Jukka Puoliväli

3.0k citations

51 papers · 2.3k indexed · h-index 24

Physiology top 2%
Cellular and Molecular Neuroscience top 2%
Molecular Biology top 10%
Genetics top 5%
Endocrinology, Diabetes and Metabolism top 5%

Co-authors: Heikki Tanila Taneli Heikkinen Thomas van Groen Nga Bien‐LyJun WangLennart Mucke Eliezer Masliah Inga Kadish
Topics: Alzheimer's disease research and treatments (19 papers)Neuroscience and Neuropharmacology Research (13 papers)Estrogen and related hormone effects (9 papers)
Cited by: Behavioral Neuroscience Cellular and Molecular Neuroscience Biological Psychiatry
Journals: Proceedings of the National Academy of Sciences Journal of Neuroscience PLoS ONE
Partner nations: Finland United States Netherlands

In The Last Decade

Jukka Puoliväli

51 papers receiving 2.2k citations

Peers

Countries citing papers authored by Jukka Puoliväli

Since Specialization

Citations

This map shows the geographic impact of Jukka Puoliväli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jukka Puoliväli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jukka Puoliväli more than expected).

Fields of papers citing papers by Jukka Puoliväli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jukka Puoliväli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jukka Puoliväli. The network helps show where Jukka Puoliväli may publish in the future.

Co-authorship network of co-authors of Jukka Puoliväli

This figure shows the co-authorship network connecting the top 25 collaborators of Jukka Puoliväli. A scholar is included among the top collaborators of Jukka Puoliväli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jukka Puoliväli. Jukka Puoliväli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	BMN 351-Induced Exon Skipping and Dystrophin Expression in Skeletal and Cardiac Muscle Lead to Preservation of Motor Function in a Mouse Model of Exon 51 Skip-Amenable Duchenne Muscular Dystrophy 2025 ·Nucleic Acid Therapeutics ·(unknown),(unknown),Joshua Henshaw,Kevin Larimore,Jukka Puoliväli,(unknown),(unknown),Stephen Brennan,(unknown),Monika Abedin Sigg,Charles O’Neill	2
2	Targeting a Novel Site in Exon 51 with Antisense Oligonucleotides Induces Enhanced Exon Skipping in a Mouse Model of Duchenne Muscular Dystrophy 2025 ·Nucleic Acid Therapeutics ·(unknown),(unknown),Joshua Henshaw,Kevin Larimore,Andrew C. Melton,Jukka Puoliväli,(unknown),(unknown),Stephen O. Brennan,(unknown),Monika Abedin Sigg,Brett E. Crawford,(unknown),Steven Froelich,Josh C. Woloszynek,Charles O’Neill	1
3	Vertigoheel promotes rodent cognitive performance in multiple memory tests 2023 ·Frontiers in Neuroscience ·(unknown),Taneli Heikkinen,Kimmo Lehtimäki,Kaisa M. A. Paldanius,Jukka Puoliväli,Raimo Pussinen,Emile Andriambeloson,(unknown),Stéphanie Wagner,Cathrin Schnack,(unknown),Bjoern von Einem,Christine A. F. Von Arnim,Yvonne Burmeister,Kathrin Weyer,Bernd Seilheimer	2
4	Detailed genetic and functional analysis of the hDMDdel52/mdx mouse model 2020 ·PLoS ONE ·(unknown),(unknown),Maaike van Putten,(unknown),Chantal Beekman,Jukka Puoliväli,Timo Bragge,Toni Ahtoniemi,Jeroen Knijnenburg,(unknown),Yavuz Ariyürek,Annemieke Aartsma‐Rus,J. van Deutekom,Nicole A. Datson	22
5	Using a State-of-the-Art Toolbox to Evaluate Molecular and Functional Readouts of Antisense Oligonucleotide-Induced Exon Skipping in mdx Mice 2019 ·Nucleic Acid Therapeutics ·Nicole A. Datson,(unknown),Anneke A. M. Janson,(unknown),(unknown),(unknown),Jukka Puoliväli,Kimmo Lehtimäki,Timo Bragge,Toni Ahtoniemi,Judith C. van Deutekom	6
6	Suppression of Mutant Protein Expression in SCA3 and SCA1 Mice Using a CAG Repeat-Targeting Antisense Oligonucleotide 2019 ·Molecular Therapy — Nucleic Acids ·(unknown),(unknown),(unknown),(unknown),Ruurd C. Verheul,Sieto Bosgra,(unknown),Jukka Puoliväli,(unknown),J.C.T. van Deutekom,Nicole A. Datson	37
7	Impaired Performance of the Q175 Mouse Model of Huntington’s Disease in the Touch Screen Paired Associates Learning Task 2018 ·Frontiers in Behavioral Neuroscience ·(unknown),Teija Parkkari,Taneli Heikkinen,Jukka Puoliväli,Larry C. Park,Roger Cachope,Maksym V. Kopanitsa	7
8	Rescue of cognitive-aging by administration of a neurogenic and/or neurotrophic compound 2014 ·Neurobiology of Aging ·Silvia Bolognin,Mario Buffelli,Jukka Puoliväli,Khalid Iqbal	45
9	Characterization of Neurophysiological and Behavioral Changes, MRI Brain Volumetry and 1H MRS in zQ175 Knock-In Mouse Model of Huntington's Disease 2012 ·PLoS ONE ·Taneli Heikkinen,Kimmo Lehtimäki,Nina Vartiainen,Jukka Puoliväli,(unknown),Jacob R. Glaser,Amyaouch Bradaïa,(unknown),(unknown),Outi Kontkanen,Juha Yrjänheikki,Bruno Buisson,David Howland,Vahri Beaumont,Ignacio Muñoz-Sanjuán,Larry C. Park	188
10	Neuroprotective properties of the non-peptidyl radical scavenger IAC in rats following transient focal cerebral ischemia 2008 ·Brain Research ·Antti Nurmi,(unknown),Jukka Puoliväli,Raimo Pussinen,Antonio Soleti,(unknown),(unknown),(unknown),Juha Yrjänheikki,Donatella Canistro,Moreno Paolini	5
11	Reduction in Mitochondrial Superoxide Dismutase Modulates Alzheimer's Disease-Like Pathology and Accelerates the Onset of Behavioral Changes in Human Amyloid Precursor Protein Transgenic Mice 2006 ·Journal of Neuroscience ·Luke Esposito,Jacob Raber,(unknown),Fengrong Yan,(unknown),Nga Bien‐Ly,Jukka Puoliväli,Kimberly Scearce‐Levie,Eliezer Masliah,Lennart Mucke	215
12	Fyn Kinase Induces Synaptic and Cognitive Impairments in a Transgenic Mouse Model of Alzheimer's Disease 2005 ·Journal of Neuroscience ·Jeannie Chin,Jorge J. Palop,Jukka Puoliväli,(unknown),Nga Bien‐Ly,Hertzel C. Gerstein,Kimberly Scearce‐Levie,Eliezer Masliah,Lennart Mucke	265
13	Locomotor activity and evoked dopamine release are reduced in mice overexpressing A30P-mutated human α-synuclein 2005 ·Neurobiology of Disease ·Leonid Yavich,Mari Oksman,Heikki Tanila,(unknown),Mikko Hiltunen,Thomas van Groen,Jukka Puoliväli,Pekka T. Männistö,J. Arturo García‐Horsman,Ewen MacDonald,Konrad Beyreuther,Tobias Hartmann,Pekka Jäkälä	77
14	Hypothermia in mice tested in Morris water maze 2003 ·Behavioural Brain Research ·(unknown),(unknown),Mikko Harri,Heikki Tanila,Jukka Puoliväli	97
15	Gender differences in the amount and deposition of amyloidβ in APPswe and PS1 double transgenic mice 2003 ·Neurobiology of Disease ·Jun Wang,Heikki Tanila,Jukka Puoliväli,Inga Kadish,Thomas van Groen	253
16	Hippocampal Aβ42 Levels Correlate with Spatial Memory Deficit in APP and PS1 Double Transgenic Mice 2002 ·Neurobiology of Disease ·Jukka Puoliväli,Jun Wang,Taneli Heikkinen,Matti Heikkilä,Tero Tapiola,Thomas van Groen,Heikki Tanila	102
17	Seladin-1 transcription is linked to neuronal degeneration in Alzheimer’s disease 2002 ·Neuroscience ·Susan Iivonen,Mikko Hiltunen,Irina Alafuzoff,Arto Mannermaa,(unknown),Jukka Puoliväli,Antero Salminen,Seppo Helisalmi,Hilkka Soininen	75
18	Effects of Ovariectomy and Estrogen Treatment on Learning and Hippocampal Neurotransmitters in Mice 2002 ·Hormones and Behavior ·Taneli Heikkinen,Jukka Puoliväli,Li Liu,(unknown),Heikki Tanila	100
19	Estrogen treatment alleviates NMDA-antagonist induced hippocampal LTP blockade and cognitive deficits in ovariectomized mice 2002 ·Neurobiology of Learning and Memory ·Irina Gureviciene,Jukka Puoliväli,Raimo Pussinen,Jun Wang,Heikki Tanila,Aarne Ylinen	32
20	Moderate cortical EEG changes in apolipoprotein E-deficient mice during ageing and scopolamine treatment but not after nucleus basalis lesion 1999 ·Psychopharmacology ·Jukka Puoliväli,Laurent Pradier,P. Riekkinen	2

About Jukka Puoliväli

Jukka Puoliväli is a scholar working on Behavioral Neuroscience, Cellular and Molecular Neuroscience and Physiology, having authored 51 papers that have together received 2.3k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (19 papers), Neuroscience and Neuropharmacology Research (13 papers) and Estrogen and related hormone effects (9 papers). The work is most often cited by research in Behavioral Neuroscience (244 citations), Cellular and Molecular Neuroscience (881 citations) and Biological Psychiatry (109 citations). Jukka Puoliväli has collaborated with scholars based in Finland, United States and Netherlands. Frequent co-authors include Heikki Tanila, Taneli Heikkinen, Thomas van Groen, Nga Bien‐Ly, Jun Wang, Lennart Mucke, Eliezer Masliah, Inga Kadish, Kimberly Scearce‐Levie and Jeannie Chin. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact